HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eiji Miyoshi Selected Research

matriptase

5/2006Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues--its possible role in prolonged stability in vivo by aberrant glycosylation.
2/2004Addition of beta1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin.
5/2002Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eiji Miyoshi Research Topics

Disease

99Neoplasms (Cancer)
10/2023 - 03/2002
33Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 11/2003
28Hepatocellular Carcinoma (Hepatoma)
04/2023 - 08/2002
24Neoplasm Metastasis (Metastasis)
12/2016 - 03/2002
21Inflammation (Inflammations)
04/2023 - 12/2008
15Liver Cirrhosis (Hepatic Cirrhosis)
05/2023 - 10/2003
14Carcinoma (Carcinomatosis)
10/2016 - 03/2002
11Colonic Neoplasms (Colon Cancer)
12/2022 - 03/2002
11Carcinogenesis
04/2016 - 05/2002
9Non-alcoholic Fatty Liver Disease
01/2022 - 01/2013
8Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2016 - 05/2008
7Liver Diseases (Liver Disease)
05/2023 - 01/2015
7Crohn Disease (Crohn's Disease)
01/2021 - 05/2008
7Stomach Neoplasms (Stomach Cancer)
10/2016 - 05/2002
6Colorectal Neoplasms (Colorectal Cancer)
10/2023 - 08/2008
6Fibrosis (Cirrhosis)
01/2022 - 10/2014
6Colitis
12/2020 - 08/2008
5Infections
03/2024 - 11/2016
5Prostatic Neoplasms (Prostate Cancer)
01/2022 - 07/2014
5Ulcerative Colitis
01/2021 - 05/2008
5Chronic Pancreatitis
12/2018 - 05/2008
5Thyroid Neoplasms (Thyroid Cancer)
01/2010 - 07/2003
5Emphysema
05/2009 - 11/2005
4Lung Neoplasms (Lung Cancer)
03/2023 - 03/2004
4Cholangiocarcinoma
01/2023 - 02/2005
4Chronic Hepatitis (Chronic Active Hepatitis)
01/2023 - 10/2003
4Alzheimer Disease (Alzheimer's Disease)
04/2016 - 03/2005
3Adenocarcinoma
01/2017 - 10/2015
3Starvation
12/2014 - 06/2006
3Papillary Carcinoma
11/2008 - 11/2003
2Hepatitis B
01/2023 - 04/2022
2Hepatic Encephalopathy
01/2022 - 07/2021
2Fatty Liver
06/2020 - 06/2012
2Obesity
06/2020 - 06/2016
2Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2020 - 06/2016

Drug/Important Bio-Agent (IBA)

45OligosaccharidesIBA
12/2021 - 05/2002
39Proteins (Proteins, Gene)FDA Link
03/2024 - 05/2002
39Biomarkers (Surrogate Marker)IBA
10/2023 - 02/2006
37Polysaccharides (Glycans)IBA
03/2024 - 05/2005
29HaptoglobinsIBA
10/2023 - 08/2002
25Tumor Biomarkers (Tumor Markers)IBA
01/2023 - 06/2006
25alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA
11/2016 - 01/2004
22LectinsIBA
01/2023 - 08/2002
18EnzymesIBA
01/2023 - 03/2004
17Glycoproteins (Glycoprotein)IBA
03/2024 - 05/2002
13GlycosyltransferasesIBA
11/2016 - 05/2002
12Monoclonal AntibodiesIBA
10/2023 - 07/2003
11FucoseIBA
01/2023 - 11/2002
10Carrier Proteins (Binding Protein)IBA
05/2023 - 07/2003
10AntigensIBA
12/2018 - 03/2002
9EpitopesIBA
01/2023 - 07/2010
9AcetylglucosamineIBA
04/2016 - 05/2006
8AsparagineIBA
11/2016 - 03/2004
7alpha-Fetoproteins (alpha-Fetoprotein)IBA
04/2023 - 10/2006
7LigandsIBA
06/2022 - 01/2004
7Immunoglobulin G (IgG)IBA
04/2016 - 05/2008
6AntibodiesIBA
06/2022 - 01/2013
5FucosyltransferasesIBA
01/2023 - 07/2014
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2022 - 07/2009
5Peptides (Polypeptides)IBA
01/2020 - 03/2005
5ImmunosorbentsIBA
01/2020 - 11/2008
5CarbohydratesIBA
01/2017 - 03/2002
4CytokinesIBA
12/2022 - 01/2016
4polylactosamineIBA
12/2020 - 07/2012
4Dextrans (Dextran)FDA Link
12/2020 - 05/2012
4VaccinesIBA
01/2017 - 03/2013
4Sulfonic AcidsIBA
04/2016 - 08/2008
4Galectin 3 (LGALS3)IBA
01/2014 - 11/2008
4A-factor (Streptomyces)IBA
01/2010 - 06/2006
3Conditioned Culture MediaIBA
05/2023 - 06/2006
3LipidsIBA
01/2023 - 12/2010
3Guanosine Diphosphate Fucose (GDP Fucose)IBA
12/2022 - 12/2007
3Prostate-Specific Antigen (Semenogelase)IBA
01/2022 - 01/2021
3sodium sulfate (sodium bisulfate)FDA LinkGeneric
12/2020 - 05/2012
3Fetal Proteins (Fetoprotein)IBA
01/2019 - 09/2012
3alpha-2-HS-GlycoproteinIBA
01/2017 - 03/2015
3Cadherins (E-Cadherin)IBA
10/2016 - 05/2008
3Messenger RNA (mRNA)IBA
07/2014 - 04/2006
3Epidermal Growth Factor (EGF)IBA
10/2012 - 05/2007
3Peptide Hydrolases (Proteases)FDA Link
07/2010 - 03/2005
3Guanosine Diphosphate (GDP)IBA
07/2010 - 11/2002
3Matrix Metalloproteinases (MMPs)IBA
01/2008 - 11/2005
3PhytohemagglutininsIBA
09/2007 - 03/2004
3matriptaseIBA
05/2006 - 05/2002
2Amyloid beta-PeptidesIBA
03/2024 - 11/2007
2IntegrinsIBA
03/2024 - 05/2008
2Membrane Proteins (Integral Membrane Proteins)IBA
03/2023 - 04/2022
2Antiviral Agents (Antivirals)IBA
01/2023 - 01/2022
2sodium-bile acid cotransporterIBA
01/2023 - 11/2016
2Cisplatin (Platino)FDA LinkGeneric
01/2023 - 11/2003
2Blood Proteins (Serum Proteins)IBA
01/2023 - 06/2012
2Mannose (D-Mannose)IBA
01/2023 - 09/2008
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
06/2022 - 09/2021
2Immunoglobulins (Immunoglobulin)IBA
04/2022 - 04/2011
2ProteomeIBA
01/2022 - 07/2011
2Rifaximin (L 105)FDA Link
01/2022 - 07/2021
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 12/2008

Therapy/Procedure

16Therapeutics
05/2023 - 06/2008
8Immunotherapy
01/2022 - 07/2010
2Drug Therapy (Chemotherapy)
12/2021 - 01/2015